Repository logo
  • Log In
    Log in via Symplectic to deposit your publication(s).
Repository logo
  • Communities & Collections
  • Research Outputs
  • Statistics
  • Log In
    Log in via Symplectic to deposit your publication(s).
  1. Home
  2. Faculty of Medicine
  3. Faculty of Medicine
  4. International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1) pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE
 
  • Details
International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1) pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE
File(s)
International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE.pdf (878.12 KB)
Published version
Author(s)
Laurie, KL
Engelhardt, OG
Wood, J
Heath, A
Katz, JM
more
Type
Journal Article
Abstract
The microneutralization assay is commonly used to detect antibodies to influenza virus, and multiple protocols are used worldwide. These protocols differ in the incubation time of the assay as well as in the order of specific steps, and even within protocols there are often further adjustments in individual laboratories. The impact these protocol variations have on influenza serology data is unclear. Thus, a laboratory comparison of the 2-day enzyme-linked immunosorbent assay (ELISA) and 3-day hemagglutination (HA) microneutralization (MN) protocols, using A(H1N1)pdm09, A(H3N2), and A(H5N1) viruses, was performed by the CONSISE Laboratory Working Group. Individual laboratories performed both assay protocols, on multiple occasions, using different serum panels. Thirteen laboratories from around the world participated. Within each laboratory, serum sample titers for the different assay protocols were compared between assays to determine the sensitivity of each assay and were compared between replicates to assess the reproducibility of each protocol for each laboratory. There was good correlation of the results obtained using the two assay protocols in most laboratories, indicating that these assays may be interchangeable for detecting antibodies to the influenza A viruses included in this study. Importantly, participating laboratories have aligned their methodologies to the CONSISE consensus 2-day ELISA and 3-day HA MN assay protocols to enable better correlation of these assays in the future.
Date Issued
2015-06-24
Date Acceptance
2015-06-03
Citation
Clinical and Vaccine Immunology, 2015, 22 (8), pp.957-964
URI
http://hdl.handle.net/10044/1/41167
DOI
https://www.dx.doi.org/10.1128/CVI.00278-15
ISSN
1556-6811
Publisher
American Society for Microbiology
Start Page
957
End Page
964
Journal / Book Title
Clinical and Vaccine Immunology
Volume
22
Issue
8
Copyright Statement
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
License URL
http://creativecommons.org/licenses/by-nc-sa/4.0/
Subjects
Science & Technology
Life Sciences & Biomedicine
Immunology
Infectious Diseases
Microbiology
SEROLOGIC ASSAYS
INFECTION
ANTIBODY
REPRODUCIBILITY
H5N1
Animals
Antibodies, Viral
Enzyme-Linked Immunosorbent Assay
Ferrets
Humans
Influenza A Virus, H1N1 Subtype
Influenza A Virus, H5N1 Subtype
Influenza, Human
International Cooperation
Neutralization Tests
Orthomyxoviridae Infections
Reproducibility of Results
Sensitivity and Specificity
CONSISE Laboratory Working Group participants
1107 Immunology
Publication Status
Published
About
Spiral Depositing with Spiral Publishing with Spiral Symplectic
Contact us
Open access team Report an issue
Other Services
Scholarly Communications Library Services
logo

Imperial College London

South Kensington Campus

London SW7 2AZ, UK

tel: +44 (0)20 7589 5111

Accessibility Modern slavery statement Cookie Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback